Citigroup Maintains Buy on Mirati Therapeutics, Lowers Price Target to $127
Citigroup analyst Yigal Nochomovitz maintains Mirati Therapeutics (NASDAQ:MRTX) with a Buy and lowers the price target from $208 to $127.
MKM Partners Maintains Buy on Mattel, Lowers Price Target to $30
MKM Partners analyst Eric Handler maintains Mattel (NASDAQ:MAT) with a Buy and lowers the price target from $34 to $30.
MKM Partners Maintains Buy on Hasbro, Lowers Price Target to $105
MKM Partners analyst Eric Handler maintains Hasbro (NASDAQ:HAS) with a Buy and lowers the price target from $118 to $105.
Citigroup Maintains Buy on Warner Bros.Discovery, Lowers Price Target to $29
Citigroup analyst Jason Bazinet maintains Warner Bros.Discovery (NASDAQ:WBD) with a Buy and lowers the price target from $40 to $29.
Citigroup Maintains Buy on Walt Disney, Lowers Price Target to $145
Citigroup analyst Jason Bazinet maintains Walt Disney (NYSE:DIS) with a Buy and lowers the price target from $165 to $145.
Raymond James Upgrades First Mid Bancshares to Outperform, Announces $45 Price Target
Raymond James analyst Daniel Tamayo upgrades First Mid Bancshares (NASDAQ:FMBH) from Market Perform to Outperform and announces $45 price target.
Raymond James Downgrades PacWest Banc to Market Perform
Raymond James analyst David Long downgrades PacWest Banc (NASDAQ:PACW) from Strong Buy to Market Perform.
Raymond James Maintains Outperform on Azul, Lowers Price Target to $12
Raymond James analyst Savanthi Syth maintains Azul (NYSE:AZUL) with a Outperform and lowers the price target from $22 to $12.
Citigroup Maintains Buy on Spotify Technology, Lowers Price Target to $150
Citigroup analyst Jason Bazinet maintains Spotify Technology (NYSE:SPOT) with a Buy and lowers the price target from $165 to $150.
Raymond James Maintains Strong Buy on Huntington Bancshares, Lowers Price Target to $16
Raymond James analyst David Long maintains Huntington Bancshares (NASDAQ:HBAN) with a Strong Buy and lowers the price target from $18 to $16.